5-Amino-1MQ targets the substrate binding site of NNMT the nicotinamide binding pocket competitively inhibiting nicotinamide methylation with an IC50 of 1.2 M under reference assay conditions
Mechanistic summaries on this page are provided for laboratory reference and should be interpreted within controlled experimental settings only. In diet-induced obese (DIO) mice, treatment with 5-Amino-1MQ at 20 mg/kg/day for 11 days via subcutaneous injection reduced body weight by approximately 5.1%, epididymal fat pad mass by 35%, adipocyte size by more than 30%, and plasma cholesterol by 30%, with no changes in food intake or observable adverse effects (Neelakantan et al., 2017)
In response to the failures of B12 therapy by MDs, naturopathic doctors (NDs) claimed that typical B12 shots used cyanocobalamin, an inactive form of B12 that didnt work well
Studies have found effects on lipogenic enzyme inhibition (reducing new fat formation) and potential thermogenic activation in brown adipose tissue
The extensive safety database across multiple clinical trials and animal toxicology studies provides reassurance about AOD-9604s tolerability and absence of serious adverse effects
Sources NIH Office of Dietary Supplements, Vitamin B12 Fact Sheet NIH Office of Dietary Supplements, Choline Fact Sheet MedlinePlus, Cyanocobalamin Injection Mayo Clinic, Vitamin B12 Injections and Weight Loss NCBI Bookshelf, Essential Amino Acids PubMed, Inositol Phosphate Signaling Network The American Journal of Clinical Nutrition, Lipotropic Agents and Lipid Transport
